153 related articles for article (PubMed ID: 33454586)
1. Chewing tobacco may act as a risk factor for dysplastic transformation of squamous cells in Oral leukoplakia- A cytochemistry based approach.
Bhattacharyya S; Ray S; Saha D; Mustafi SM; Alam N; Sarkar A; Murmu N
Pathol Res Pract; 2021 Feb; 218():153287. PubMed ID: 33454586
[TBL] [Abstract][Full Text] [Related]
2. Oral premalignant lesions: from a clinical perspective.
Amagasa T; Yamashiro M; Uzawa N
Int J Clin Oncol; 2011 Feb; 16(1):5-14. PubMed ID: 21225307
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of p53 protein in betel- and tobacco-related human oral dysplasia and squamous-cell carcinoma in India.
Kaur J; Srivastava A; Ralhan R
Int J Cancer; 1994 Aug; 58(3):340-5. PubMed ID: 8050814
[TBL] [Abstract][Full Text] [Related]
4. A correlation between oral mucosal lesions and various quid-chewing habit patterns: A cross-sectional study.
Avinash Tejasvi ML; Anulekha CK; Afroze MM; Shenai KP; Chatra L; Bhayya H
J Cancer Res Ther; 2019; 15(3):620-624. PubMed ID: 31169230
[TBL] [Abstract][Full Text] [Related]
5. Recurrence rates after surgical removal of oral leukoplakia-A prospective longitudinal multi-centre study.
Sundberg J; Korytowska M; Holmberg E; Bratel J; Wallström M; Kjellström E; Blomgren J; Kovács A; Öhman J; Sand L; Hirsch JM; Giglio D; Kjeller G; Hasséus B
PLoS One; 2019; 14(12):e0225682. PubMed ID: 31810078
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical expression of EGFR in oral leukoplakia: association with clinicopathological features and cellular proliferation.
Ribeiro DC; Gleber-Netto FO; Sousa SF; Bernardes VD; Guimarães-Abreu MH; Aguiar MC
Med Oral Patol Oral Cir Bucal; 2012 Sep; 17(5):e739-44. PubMed ID: 22322523
[TBL] [Abstract][Full Text] [Related]
7. Exfoliative cytological assessment of apparently normal buccal mucosa among quid chewers using argyrophilic nucleolar organizer region counts and Papanicolaou staining.
Mohan BC; Angadi PV
Acta Cytol; 2013; 57(2):164-70. PubMed ID: 23406917
[TBL] [Abstract][Full Text] [Related]
8. Oral mucosal lesions found in smokeless tobacco users.
Grady D; Greene J; Daniels TE; Ernster VL; Robertson PB; Hauck W; Greenspan D; Greenspan J; Silverman S
J Am Dent Assoc; 1990 Jul; 121(1):117-23. PubMed ID: 2370378
[TBL] [Abstract][Full Text] [Related]
9. The precancer risk of betel quid chewing, tobacco use and alcohol consumption in oral leukoplakia and oral submucous fibrosis in southern Taiwan.
Lee CH; Ko YC; Huang HL; Chao YY; Tsai CC; Shieh TY; Lin LM
Br J Cancer; 2003 Feb; 88(3):366-72. PubMed ID: 12569378
[TBL] [Abstract][Full Text] [Related]
10. Accumulation of the p53 tumor-suppressor gene product in oral leukoplakia.
Wood MW; Medina JE; Thompson GC; Houck JR; Min KW
Otolaryngol Head Neck Surg; 1994 Dec; 111(6):758-63. PubMed ID: 7527509
[TBL] [Abstract][Full Text] [Related]
11. Altered β-catenin expression in oral mucosal dysplasia: a comparative study.
Silva BS; Castro CA; Von Zeidler SL; Sousa SC; Batista AC; Yamamoto-Silva FP
J Appl Oral Sci; 2015 Oct; 23(5):472-8. PubMed ID: 26537717
[TBL] [Abstract][Full Text] [Related]
12. Smokeless tobacco (khaini) extracts modulate gene expression in epithelial cell culture from an oral hyperplasia.
Rohatgi N; Kaur J; Srivastava A; Ralhan R
Oral Oncol; 2005 Sep; 41(8):806-20. PubMed ID: 15979382
[TBL] [Abstract][Full Text] [Related]
13. Oral mucosal smokeless tobacco lesions among adolescents in the United States.
Tomar SL; Winn DM; Swango PA; Giovino GA; Kleinman DV
J Dent Res; 1997 Jun; 76(6):1277-86. PubMed ID: 9168861
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of COX-2, EGFR, and p53 as biomarkers of non-dysplastic oral leukoplakias.
Prado SM; Cedrún JL; Rey RL; Villaamil VM; García AA; Ayerbes MV; Aparicio LA
Exp Mol Pathol; 2010 Oct; 89(2):197-203. PubMed ID: 20599939
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of TGF-alpha and EGFR expression in oral leukoplakia and oral submucous fibrosis by quantitative immunohistochemistry.
Srinivasan M; Jewell SD
Oncology; 2001; 61(4):284-92. PubMed ID: 11721175
[TBL] [Abstract][Full Text] [Related]
16. Tobacco use and oral leukoplakia.
Bánóczy J; Gintner Z; Dombi C
J Dent Educ; 2001 Apr; 65(4):322-7. PubMed ID: 11336117
[TBL] [Abstract][Full Text] [Related]
17. Alcohol drinking, body mass index and the risk of oral leukoplakia in an Indian population.
Hashibe M; Sankaranarayanan R; Thomas G; Kuruvilla B; Mathew B; Somanathan T; Parkin DM; Zhang ZF
Int J Cancer; 2000 Oct; 88(1):129-34. PubMed ID: 10962450
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of phosphatidyl inositol synthase overexpression in oral cancer.
Kaur J; Sawhney M; Dattagupta S; Shukla NK; Srivastava A; Ralhan R
BMC Cancer; 2010 Apr; 10():168. PubMed ID: 20426864
[TBL] [Abstract][Full Text] [Related]
19. Tobacco-induced oral lesions.
Crews KC; Taybos GM; Krolls SO
Mouth; 1999; 19(3):22-4. PubMed ID: 10873144
[No Abstract] [Full Text] [Related]
20. DNA hypermethylation of sirtuin 1 (SIRT1) caused by betel quid chewing-a possible predictive biomarker for malignant transformation.
Islam S; Uehara O; Matsuoka H; Kuramitsu Y; Adhikari BR; Hiraki D; Toraya S; Jayawardena A; Saito I; Muthumala M; Nagayasu H; Abiko Y; Chiba I
Clin Epigenetics; 2020 Jan; 12(1):12. PubMed ID: 31931863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]